Dr. Murad M. Talahma, MD

Dr. Talahma practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

Dr. Talahma's NPI, 1043534449, was assigned on March 15, 2010. Dr. Talahma graduated from Jordan University of Science and Technology FOM in 2007. Dr. Talahma holds Florida license ME156540.

Dr. Talahma's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.

Dr. Talahma's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. Dr. Talahma is also affiliated with AdventHealth Waterman. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Talahma to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Talahma practices, 2 sites in all. Vendor and product names are available with a free account.

Neurocritical care is Dr. Talahma's primary specialty in the NPI Registry, under taxonomy code 2084A2900X. Dr. Talahma is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Talahma's licenses on file in 7 states: Florida, Arizona, Alabama, Louisiana, Mississippi, Washington and Ohio.

Dmand AI lists cerebrovascular disease and stroke among the conditions Dr. Talahma treats.

CMS data shows 388 Medicare services from Dr. Talahma across 3 procedure codes in 2024, for 174 Medicare patients. Medicare paid $53,700 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 174 Medicare patients who saw Dr. Talahma in 2024. The largest group is 75 to 84, with 64 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Talahma's median patient age at 70, with 48% women.

In 2018, Dr. Talahma wrote 12 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $221 in total drug cost. In 2017, CMS named 12 claims across 1 drug.

Dr. Talahma accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Talahma, published from 2014 to 2020. 2015 was the busiest year, with 2. The most frequent topics are Subarachnoid Hemorrhage and Takotsubo Cardiomyopathy. Dr. Talahma has published most often in Clin Neurol Neurosurg. Dr. Talahma's most frequent co-authors are Ayham Alkhachroum, MD, Giuseppe Ciccotto, MD, MPH and Ifeanyi Obianyo Iwuchukwu, MD.

CMS Open Payments shows 10 general payments to Dr. Talahma from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Olympus America Inc. paid the most, $96.

Dr. Talahma graduated from Jordan University of Science and Technology FOM in 2007.

Dr. Talahma is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.